/
ALTHX.PA
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
THX Pharma
Theranexus, a biopharmaceutical enterprise, specializes in the creation of potential medications for ailments affecting the central nervous system. Their primary investigational compound, THN102, is presently undergoing Phase II clinical evaluation for conditions related to sleep and wake cycles. Furthermore, they are developing THN201 to target neurocognitive challenges associated with Alzheimer's disease, and THN101 for the management of neuropathic discomfort. This company commenced operations in 2013 and is situated in Lyon, France.
www.theranexus.com- Employees
- 12
- IPO / List date
- Oct 30, 2017
- HQ
- FR
Held by traders on TradeandTell
No one on the platform currently holds ALTHX.PA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ALTHX.PA as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ALTHX.PA yet.